I use EncoderPro and if you go to D68.51 (or the ICD 9 code 289.81), under the code it lists problems that fall within that code category and Factor V Leiden Mutation is in the list. But, I then researched the difference between "mutation vs heterozygosity".
In order to find out if you have factor V Leiden, a screening can be done by taking a sample of your blood to test for activated protein C resistance. A positive result may mean that you have the factor V Leiden mutation.
If you have a mutation in your F5 gene, this causes factor V Leiden thrombophilia. It does not affect everyone who has the mutation, but it can cause problems with your blood’s coagulation factor V.
D68.52 is a billable ICD code used to specify a diagnosis of prothrombin gene mutation. ICD-10 Code D68.51, Activated protein C resistance. D68.59 is a billable ICD code used to specify a diagnosis of other primary thrombophilia. (To the best of my knowledge)
Factor v leiden mutation (r506q) is the most common cause of apc resistance. An abnormality that refers to mutation of factor v leiden, which is a variant of human factor v. It results in thrombophilia, deep vein thrombosis, and a slightly increased risk of miscarriage.
Group 1CodeDescription81241F5 (COAGULATION FACTOR V) (EG, HEREDITARY HYPERCOAGULABILITY) GENE ANALYSIS, LEIDEN VARIANT81291MTHFR (5,10-METHYLENETETRAHYDROFOLATE REDUCTASE) (EG, HEREDITARY HYPERCOAGULABILITY) GENE ANALYSIS, COMMON VARIANTS (EG, 677T, 1298C)1 more row
D68. 2 - Hereditary deficiency of other clotting factors | ICD-10-CM.
ICD-10 code D68. 59 for Other primary thrombophilia is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
LOINC® Codes, Performing Laboratory If Factor V Leiden is Heterozygous for the R506Q mutation, then HR2 testing will be performed at an additional charge (CPT code: 81400).
Factor V Leiden (FAK-tur five LIDE-n) is a mutation of one of the clotting factors in the blood. This mutation can increase your chance of developing abnormal blood clots, most commonly in your legs or lungs. Most people with factor V Leiden never develop abnormal clots.
Heterozygous means that the 2 copies of a gene are different. In your case, one of your Factor V gene codes is for normal clotting Factor V and the other Factor V gene code is for Factor V Leiden. There is more risk of a blood clot if both gene codes are for Factor V Leiden (ie in the homozygous state).
This testing is considered investigational and is NOT a Medicare benefit.
Factor V deficiency is caused by a lack of factor V. When certain blood clotting factors are low or missing, your blood does not clot properly. Factor V deficiency is rare. It may be caused by: A defective factor V gene passed down through families (inherited)
ICD-10 code D68. 69 for Other thrombophilia is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
If you have thrombophilia, it means your blood can form clots too easily. Blood clots can be very serious and need to be treated quickly. Thrombophilia increases your risk of: deep vein thrombosis (DVT), a blood clot in a vein, usually the leg.
A: When physicians use a prothrombin time test (reported with CPT code 85610) to monitor patients on anticoagulant drugs, Medicare pays the entity that performed the test. Its payment for the test is based on the geographically specific laboratory test fee schedule.
This testing is considered investigational and is NOT a Medicare benefit.
A: When physicians use a prothrombin time test (reported with CPT code 85610) to monitor patients on anticoagulant drugs, Medicare pays the entity that performed the test. Its payment for the test is based on the geographically specific laboratory test fee schedule.
1: Abnormal coagulation profile.
Who is likely to have factor V Leiden (FVL)? FVL can only be inherited from a parent who has the mutation, which is more common among individuals of Northern European ancestry. Children from a parent with heterozygous FVL mutation have a 25% chance of having inherited it from the parent who has the mutation.
This test detects the factor V R506Q (Leiden) mutation and will help identify those individuals who are at increased risk of thrombosis; however, increased risk of thrombosis can be caused by a variety of genetic and nongenetic factors not screened for by this assay.
Heterozygous carriers of this mutation have a four- to eightfold increased risk of thrombosis. Individuals homozygous for the mutation (ie, they have a copy of the mutation on each chromosome) carry an 80- to 100-fold risk of thrombosis.
The mutation is characterized by a guanine to adenine substitution at nucleotide 1691 in exon 10 of the factor V gene that replaces an arginine at codon 506 with a glutamine. It is designated as FV R506Q (Leiden), and confers resistance to inactivation by activated protein C.
Genetic counselors are available for health care providers to discuss results, and for information on how to order additional testing, if desired, at 800-345-4363.
All offspring of a factor V Leiden homozygote will inherit at least a single copy of the mutation. Genetic counseling is recommended for these patients. The risk of venous thrombosis increases exponentially in patients with more than one risk factor, including age, surgery, oral contraceptive use, pregnancy, elevated homocysteine levels, ...
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
A positive result may mean that you have the factor V Leiden mutation. If you or your health care provider suspect that you may be at a higher risk for factor V Leiden, you may need more information about whether your Medicare benefits cover testing.
In the human body, factor V is a protein that is necessary for proper blood clotting. Some people have a genetic mutation of the protein which is called factor V Leiden. This is a disorder that can cause a condition known as thrombophilia. If you have the factor V Leiden mutation, you are at greater risk of developing blood clots.
Because deep vein thrombosis and pulmonary embolism are serious enough to be life threatening, if you suspect that you have the genetic mutation of factor V, factor V Leiden, you should be tested to determine your risk factor for thrombophilia.
Part A (hospital insurance) covers the cost of your Factor V Leiden screening test if your physician deems it medically necessary and orders it while you are being cared for as an inpatient or in a skilled nursing facility.
This abnormal clotting most commonly occurs in either the deep veins of the legs (deep vein thrombosis), or in the lungs (pulmonary embolism). Not everyone who has factor V Leiden experiences abnormal clotting, but there is a higher risk for those that do.
Statistics indicate that factor V Leiden is the most common inherited form of thrombophilia in the United States and Europe among Caucasians. Fortunately, Medicare recipients have coverage for the necessary blood test needed to screen for this condition.
Because factor V Leiden is a hereditary condition, you may have an increased chance of having it if you have a relative with factor V Leiden. It is also more common for Caucasians of European descent to have this factor V mutation. In order to find out if you have factor V Leiden, a screening can be done by taking a sample ...